Consistently, our in vivo study showed that SETD8 overexpression reduced WNT5A expression, p-p65 expression, and inflammatory factors levels, thus improving renal dysfunction in DN rats (Fig. 7; Additional file 4: Fig. S3). The gene discussed is KMT5A; the disease is liver dysplastic nodule.